U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07500129) titled 'Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Res... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501611) titled 'Acute Cardiovascular Effects of Transcutaneous Auricular Vagus Nerve Stimulation' on March... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501234) titled 'Safety and Feasibility Study of the MitraFix(R) Transcatheter Mitral Valve System' on Marc... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501403) titled 'Impact of Protein Formulations on the Stimulation of Muscle Protein Synthesis' on March 20... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07500519) titled 'Preoperative Shock Indexes and Post-Spinal Hypotension in Cesarean Surgery' on March 18. ... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07502222) titled 'A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe A... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07502157) titled 'Massage, Oncology, Pain, Anxiety, Feasibility' on March 16. Brief Summary: The goal of th... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501325) titled 'Recombinant Tropomyosin- and Hemocyanin-Specific IgE in Children With Suspected Shrimp All... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501650) titled 'Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer' on M... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501104) titled 'Neoadjuvant Pucotenlimab Combined With Lenvatinib and Temozolomide in Resectable Stage IIB... Read More